preprint · 2025
Table 2 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib
<p>Baseline HRQoL in TBx-positive and LBx-positive patients.</p>
0 citationsDOI: https://doi.org/10.1158/1078-0432.29444938Open access